On the public citation graph
Human epidermal growth factor receptor 2 testing in gastric cancer: Recommendations of an A sia‐ P acific T ask F orce
0 signed · 74 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ijc.25516openalex-snapshot
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
inferredcites →https://doi.org/10.1007/s00428-010-0952-2openalex-snapshot
HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
inferredcites →https://doi.org/10.1007/s00428-011-1132-8openalex-snapshot
Quality assessment of HER2 testing by monitoring of positivity rates
inferredcites →https://doi.org/10.1007/s10620-005-9057-1openalex-snapshot
HER-2/neu Amplification Is an Independent Prognostic Factor in Gastric Cancer
inferredcites →https://doi.org/10.1007/s12094-011-0709-7openalex-snapshot
Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma
inferredcites →https://doi.org/10.1016/j.ejca.2012.10.018openalex-snapshot
Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
inferredcites →https://doi.org/10.1016/s0140-6736(10)61121-xopenalex-snapshot
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
inferredcites →https://doi.org/10.1038/modpathol.2011.198openalex-snapshot
HER2 testing in gastric cancer: a practical approach
inferredcites →https://doi.org/10.1038/modpathol.2012.205openalex-snapshot
Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas
inferredcites →https://doi.org/10.1038/modpathol.2012.59openalex-snapshot
The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma
inferredcites →https://doi.org/10.1046/j.1365-2559.1997.3020895.xopenalex-snapshot
Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry
inferredcites →https://doi.org/10.1093/annonc/mdi064openalex-snapshot
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
inferredcites →https://doi.org/10.1093/annonc/mdn169openalex-snapshot
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
inferredcites →https://doi.org/10.1093/annonc/mds528openalex-snapshot
Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
inferredcites →https://doi.org/10.1093/annonc/mdt232openalex-snapshot
HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance
inferredcites →https://doi.org/10.1093/jnci/djs438openalex-snapshot
Quantitative Assessment of Effect of Preanalytic Cold Ischemic Time on Protein Expression in Breast Cancer Tissues
inferredcites →https://doi.org/10.1097/pas.0b013e318244adbbopenalex-snapshot
Gastric HER2 Testing Study (GaTHER)
inferredcites →https://doi.org/10.1111/j.1365-2559.2008.03028.xopenalex-snapshot
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
inferredcites →https://doi.org/10.1111/j.1365-2559.2011.04012.xopenalex-snapshot
Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma
inferredcites →https://doi.org/10.1136/jclinpath-2012-200774openalex-snapshot
HER2/ neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer
inferredcites →https://doi.org/10.1136/jcp.2011.089847openalex-snapshot
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods
inferredcites →https://doi.org/10.1136/pgmj.2004.029330openalex-snapshot
Epidemiology of gastric cancer in Japan
inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-2272openalex-snapshot
Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
inferredcites →https://doi.org/10.1186/1746-1596-8-76openalex-snapshot
HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population
inferredcites →https://doi.org/10.1245/s10434-011-1695-2openalex-snapshot
Evaluation of HER2 Protein Expression in Gastric Carcinomas: Comparative Analysis of 1414 Cases of Whole-Tissue Sections and 595 Cases of Tissue Microarrays
inferredcites →https://doi.org/10.1245/s10434-012-2818-0openalex-snapshot
A Large Cohort of Consecutive Patients Confirmed Frequent HER2 Positivity in Gastric Carcinomas with Advanced Stages
inferredcites →https://doi.org/10.3892/or.15.1.65openalex-snapshot
Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4667606openalex-extracted
Prediction of the Optimal Number of Tumor Blocks for Her2 Assessment in Gastric Carcinoma Resection Specimens: From Clinical Data to Mathematical Model Simulations
inferred← citeshttps://doi.org/10.1007/978-981-99-0815-8_3openalex-snapshot
Pathologic and Molecular Characteristics
inferred← citeshttps://doi.org/10.1007/s00259-020-04898-5openalex-snapshot
Impact of 68Ga-NOTA-MAL-MZHER2 PET imaging in advanced gastric cancer patients and therapeutic response monitoring
inferred← citeshttps://doi.org/10.1007/s00261-025-04912-0openalex-snapshot
Radiomics-based assessment of HER2 status and prognosis in gastric cancer: a retrospective dual-center CT study
inferred← citeshttps://doi.org/10.1007/s40291-016-0205-4openalex-snapshot
A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer
inferred← citeshttps://doi.org/10.1016/j.bbcan.2021.188549openalex-snapshot
HER2-targeted therapies in gastric cancer
inferred← citeshttps://doi.org/10.1016/j.clcc.2017.01.005openalex-snapshot
HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAF
inferred← citeshttps://doi.org/10.1016/j.gie.2019.03.022openalex-snapshot
A survival guide to HER2 testing in gastric/gastroesophageal junction carcinoma
inferred← citeshttps://doi.org/10.1016/j.pathol.2017.05.009openalex-snapshot
HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program
inferred← citeshttps://doi.org/10.1016/j.pathol.2023.10.007openalex-snapshot
Clinicopathological analysis of CD47 and signal regulatory protein alpha expression in myeloid sarcoma patients: CD47 expression is a favourable prognostic factor
inferred← citeshttps://doi.org/10.1016/j.prp.2019.01.037openalex-snapshot
HER2 as a limited predictor of the therapeutic response to neoadjuvant therapy in locally advanced rectal cancer
inferred← citeshttps://doi.org/10.1016/j.prp.2020.152882openalex-snapshot
The age variation of HER2 immunohistochemistry positive rate in biopsy specimens of gastric cancer
inferred← citeshttps://doi.org/10.1016/j.prp.2020.153229openalex-snapshot
Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer
inferred← citeshttps://doi.org/10.1016/j.prp.2021.153643openalex-snapshot
HER2 promotes epithelial-mesenchymal transition through regulating osteopontin in gastric cancer
inferred← citeshttps://doi.org/10.1038/s41388-021-01976-2openalex-snapshot
Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach
inferred← citeshttps://doi.org/10.1038/s41416-026-03405-1openalex-snapshot
Comprehensive analysis of FGFR2b and its correlation with essential biomarkers, intratumoral heterogeneity, and survival in advanced gastric cancer
inferred← citeshttps://doi.org/10.1038/s41467-022-30142-9openalex-snapshot
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
inferred← citeshttps://doi.org/10.1038/s41571-019-0268-3openalex-snapshot
HER2-targeted therapies — a role beyond breast cancer
inferred← citeshttps://doi.org/10.1038/s41571-024-00924-9openalex-snapshot
HER2-targeted therapies beyond breast cancer — an update
inferred← citeshttps://doi.org/10.1097/pat.0000000000000323openalex-snapshot
Concordance of HER2 expression in paired primary and metastatic sites of gastric and gastro-oesophageal junction cancers
inferred← citeshttps://doi.org/10.1101/2021.07.13.452260openalex-snapshot
Caveolin-1 temporal modulation enhances trastuzumab and trastuzumab-drug conjugate efficacy in heterogeneous gastric cancer
inferred← citeshttps://doi.org/10.1111/ajco.12514openalex-snapshot
Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study
inferred← citeshttps://doi.org/10.1111/ajco.12653openalex-snapshot
Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study
inferred← citeshttps://doi.org/10.1111/his.13257openalex-snapshot
HER 2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks
inferred← citeshttps://doi.org/10.1136/bcr-2025-268475openalex-snapshot
Visceral crisis in HER2-positive, AFP-producing gastric cancer
inferred← citeshttps://doi.org/10.1177/03000605231154403openalex-snapshot
Human epidermal growth factor receptor-2 gene expression positivity determined by silver in situ hybridization/immunohistochemistry methods and associated factors in a cohort of Sri Lankan patients with gastric adenocarcinoma: a prospective study
inferred← citeshttps://doi.org/10.1177/1533033820926592openalex-snapshot
PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer
inferred← citeshttps://doi.org/10.1186/s13000-017-0616-5openalex-snapshot
Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
inferred← citeshttps://doi.org/10.1186/s13000-022-01230-7openalex-snapshot
Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China
inferred← citeshttps://doi.org/10.1186/s13045-026-01804-8openalex-snapshot
Chinese guidelines for HER2-targeted therapy in gastric and gastroesophageal junction adenocarcinoma (2025 Edition)
inferred← citeshttps://doi.org/10.1186/s40880-019-0349-9openalex-snapshot
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
inferred← citeshttps://doi.org/10.1360/csb-2025-5908openalex-snapshot
Progress and prospects in anti-HER2 targeted therapy for gastric cancer
inferred← citeshttps://doi.org/10.18632/aging.102415openalex-snapshot
Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment
inferred← citeshttps://doi.org/10.18632/oncotarget.16567openalex-snapshot
Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type
inferred← citeshttps://doi.org/10.18632/oncotarget.19985openalex-snapshot
Development of mesenchymal subtype gene signature for clinical application in gastric cancer
inferred← citeshttps://doi.org/10.18632/oncotarget.5368openalex-snapshot
Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens
inferred← citeshttps://doi.org/10.2214/ajr.20.23528openalex-snapshot
Dual-Energy CT–Based Nomogram for Decoding HER2 Status in Patients With Gastric Cancer
inferred← citeshttps://doi.org/10.3389/fmed.2022.803005openalex-snapshot
Pre-Clinical Study of the [18F]AlF-Labeled HER2 Affibody for Non-Invasive HER2 Detection in Gastric Cancer
inferred← citeshttps://doi.org/10.3748/wjg.v21.i39.10948openalex-snapshot
Companion diagnostics for the targeted therapy of gastric cancer
inferred← citeshttps://doi.org/10.3892/ol.2018.8731openalex-snapshot
Associations between CA19‑9 and CA125 levels and human epidermal growth factor receptor 2 overexpression in patients with gastric cancer
inferred← citeshttps://doi.org/10.4103/ijmr.ijmr_896_16openalex-snapshot
Improving accuracy of breast cancer biomarker testing in India
inferred← citeshttps://doi.org/10.4132/jptm.2017.01.24openalex-snapshot
Molecular Testing for Gastrointestinal Cancer
inferred← citeshttps://doi.org/10.4132/jptm.2020.09.23openalex-snapshot
DNA-protein biomarkers for immunotherapy in the era of precision oncology
inferred← citeshttps://doi.org/10.4132/jptm.2021.10.12openalex-snapshot
Extremely well-differentiated adenocarcinoma of the stomach: diagnostic pitfalls in endoscopic biopsy
inferred← citeshttps://doi.org/10.4143/crt.2015.155openalex-snapshot
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
inferred← citeshttps://doi.org/10.5230/jgc.2025.25.e3openalex-snapshot
Spatial and Temporal Tumor Heterogeneity in Gastric Cancer: Discordance of Predictive Biomarkers
inferred← citeshttps://doi.org/10.70675/cf7a9d8ez16a0z4bd4z870az032bea313bc2openalex-snapshot
Cancers épithéliaux de l'ovaire : évaluation des profils génomiques identifiés selon une approche phénotypique, histologique et bio-statistique
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.